249PAssessment of CPS+EG, neo-bioscore and modified neo-bioscore in breast cancer patients treated with preoperative systemic therapy: A multicenter cohort study

ConclusionsThe modified Neo-Bioscore could circumvent the limitation of CPS+EG or Neo-Bioscore. The access of appropriate treatment should be incorporated into the existing staging systems for more refined prognosis prediction.Clinical trial identificationThe trial protocol number: NCT03437837 Release date: February 19, 2018.Legal entity responsible for the studyXuening Duan AND Yimin Cui.FundingNational Key Research and Development Program of China.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research